Differential binding properties of B7-H1 and B7-DC to programmed death-1
about
The B7 family of immune-regulatory ligandsTriggering receptor expressed on myeloid cell-like transcript 2 (TLT-2) is a counter-receptor for B7-H3 and enhances T cell responsesCTLA-4 and PD-1 Pathways: Similarities, Differences, and Implications of Their InhibitionHuman Cancer Immunotherapy with PD-1/PD-L1 BlockadeIn vivo T cell activation induces the formation of CD209(+) PDL-2(+) dendritic cellsCrystal structure of the complex between programmed death-1 (PD-1) and its ligand PD-L2The Next Immune-Checkpoint Inhibitors: PD-1/PD-L1 Blockade in MelanomaProgrammed death-1 concentration at the immunological synapse is determined by ligand affinity and availability.Immune checkpoint blockade: the role of PD-1-PD-L axis in lymphoid malignancies.PD-L1 and PD-L2 modulate airway inflammation and iNKT-cell-dependent airway hyperreactivity in opposing directions.PD-L2+ dendritic cells and PD-1+ CD4+ T cells in schistosomiasis correlate with morbidity.Programmed death-1 ligand 1 interacts specifically with the B7-1 costimulatory molecule to inhibit T cell responses.Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10Interaction of human PD-L1 and B7-1.PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1.On the pathogenesis of autoimmune thyroid disease: a unifying hypothesis.Pancreatic ductal adenocarcinoma: a review of immunologic aspects.Programmed death ligand 2 in cancer-induced immune suppression.B7 family molecules as regulators of the maternal immune system in pregnancyQuantitative mass spectrometry analysis of PD-L1 protein expression, N-glycosylation and expression stoichiometry with PD-1 and PD-L2 in human melanoma.Checkpoint blockade in cancer immunotherapySignaling pathway and dysregulation of PD1 and its ligands in lymphoid malignancies.Modulation of immune response by B7 family molecules in tumor microenvironments.Targeting the B7 family of co-stimulatory molecules: successes and challenges.PD-L1 Expression in Lung Cancer.Structure-guided development of a high-affinity human Programmed Cell Death-1: Implications for tumor immunotherapy.Anti-programmed death-1 and anti-programmed death-ligand 1 antibodies in cancer therapy.Structural genomic alterations in primary mediastinal large B-cell lymphoma.Immunomodulatory Drugs: Immune Checkpoint Agents in Acute Leukemia.Programmed death-1 & its ligands: promising targets for cancer immunotherapy.Negative immune checkpoints on T lymphocytes and their relevance to cancer immunotherapy.Potential targeting of B7-H4 for the treatment of cancer.Simultaneous blockade of programmed death 1 and vascular endothelial growth factor receptor 2 (VEGFR2) induces synergistic anti-tumour effect in vivo.Programmed death-1 pathway blockade produces a synergistic antitumor effect: combined application in ovarian cancer.In situ and in silico kinetic analyses of programmed cell death-1 (PD-1) receptor, programmed cell death ligands, and B7-1 protein interaction network.A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage.Tumour CD274 (PD-L1) expression and T cells in colorectal cancer.Structure and Dynamics of PD-L1 and an Ultra-High-Affinity PD-1 Receptor Mutant.PD-1/PD-L1 Blockade: Have We Found the Key to Unleash the Antitumor Immune Response?Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer.
P2860
Q21184159-6E103C95-CFB5-4DFC-98CE-F18DBE719920Q24316331-EC7B0E0D-1E76-489D-BF51-EB3EA255D9D9Q26777563-1C191ED3-EDC0-421F-B096-474A6EFF1B29Q26786108-8A3AA74F-A23B-413A-A298-871B159DC116Q27304762-64B98AA2-D24F-4D6A-9B79-186A0565F395Q27651269-872D4071-D151-4EA0-8C5C-3A0174130E56Q28088496-47C4F07F-22AC-40EC-AE76-F286CCFACE14Q30480631-39C8C560-73E9-48DF-9C4C-CD9EEBC4318FQ33638083-EDA91ACE-3FD3-4997-B326-E4926BD53F77Q33753894-5E90454B-C599-40A9-8A38-54BD4D590843Q34556528-23FF4640-4D18-420D-A705-1BA54F08F57BQ34650346-5029C1FF-7921-4D96-90D8-6082808ECFF7Q34683647-BE40AADA-477F-4B39-B505-4E20662AD564Q34789854-2E765C50-546A-4908-ADFB-2421C172A1A7Q35201893-EFF9174D-F74B-427D-BE1B-7546AAA417D3Q35721078-0C88EB89-F9EA-43AC-B6B5-44A4D971B1FFQ35870682-CAC5B5AB-4526-4759-B13B-B15EDC573A5CQ35955151-62B5C93E-1927-4516-AD16-2D67344AF6FFQ36185034-3DEA928E-349D-4FD0-8016-A682ADCE8C0AQ36382143-F82468E3-0740-4780-8ECD-83DC9A746546Q36490768-A9D56564-7F68-47D2-851E-A768B50C34D6Q36522770-CEBC4B09-B91D-4C8C-874F-0BE550A9D207Q36569007-4A350940-19AD-43F2-974E-82E48956E71BQ36841260-8EAD760E-A4A8-4126-925E-203A1DA556E0Q37704352-83B4CC71-0110-4C19-A486-88D9F3054865Q37714274-B2A24CE4-8FE1-4104-88B6-0C2107EF44FFQ38082845-BC4F57F3-4C98-4007-AFBE-ACACEEB14579Q38267888-5D00AA71-FE10-467B-BB94-D45DB85907DCQ38485334-F81D7B01-6A6B-45AA-A2C0-550823D5F042Q38562062-EB8946B9-EDC4-4548-8702-0D64483795A0Q38636569-3FEB9198-D57C-40AA-AED0-29C940764E59Q38930119-5F884871-4D7F-4E02-B103-B81E068DA4D0Q39163764-DA64435C-1ADA-4CBF-8E6A-1DBE5805C450Q39402079-0874FC59-DC42-42CD-ABCA-8D918D844260Q40304447-FCCC73F3-5503-4333-A7B7-207080627FC1Q40437353-1F649300-51C4-4B69-92E8-ADB1DE55FC89Q40746149-EEF1B69A-95B9-44B8-A1B2-E15817A91612Q42387009-617DAA0A-596B-4598-AB30-A9F0B59F9C8FQ47120629-09610961-DB34-44B4-83FE-3836FE902DC3Q47134535-78BC5557-CE13-482D-8B59-A6AC8FD7BF75
P2860
Differential binding properties of B7-H1 and B7-DC to programmed death-1
description
2003 nî lūn-bûn
@nan
2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@ast
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@en
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@nl
type
label
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@ast
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@en
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@nl
prefLabel
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@ast
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@en
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@nl
P2093
P1476
Differential binding properties of B7-H1 and B7-DC to programmed death-1
@en
P2093
Drew M Pardoll
Haruo Kozono
Hideo Yagita
Hideyuki Iwai
Hisayo Jin
Lieping Chen
Miyuki Azuma
Noriko Otsuki
Pornpan Youngnak
P356
10.1016/S0006-291X(03)01257-9
P407
P577
2003-08-01T00:00:00Z